[Preparation of the promotion of therapeutic studies as an open planning process]

Insights

This study outlines research priorities for rheumatic diseases, focusing on methodological requirements for therapeutic trials and challenges in multicenter studies. It addresses key questions to guide future clinical rheumatology research in Germany.

Area of Science:

  • Rheumatology
  • Medical Research Policy

Background:

  • The "Health Research and Development" program initiated in 1978 aimed to integrate scientific input into research priority setting.
  • Rheumatic diseases research requires strategic planning to address knowledge gaps and improve patient outcomes.

Purpose of the Study:

  • To involve the scientific community in defining priorities for rheumatic diseases research.
  • To identify methodological requirements for effective therapeutic trials.
  • To explore conditions for successful multicenter trials in clinical rheumatology.

Main Methods:

  • A planning conference was convened, open to all interested research scientists.
  • Analysis of research needs and priorities was conducted.
  • Discussion of specific challenges in clinical rheumatology research within the Federal Republic of Germany.

Main Results:

  • Key questions regarding therapeutic trial methodology were addressed.
  • Priorities for open questions in clinical rheumatology were established.
  • Factors crucial for the success of multicenter therapeutic trials were identified.

Conclusions:

  • The study provides a framework for prioritizing rheumatic diseases research.
  • It highlights the importance of methodological rigor and collaborative efforts in clinical trials.
  • Recommendations are offered for advancing rheumatology research in Germany.

Related Concept Videos

Nursing Process for Patient and Caregiver Teaching II: Planning and Implementation01:24

Nursing Process for Patient and Caregiver Teaching II: Planning and Implementation

Planning for learning involves the development of a teaching plan. Teaching plans are similar to nursing care plans—both follow the steps of the nursing process. Planning in the teaching process involves setting goals and outcomes. Here, goals identify what a patient needs to achieve to understand a healthcare topic better, whereas the outcomes are the action to be performed by the patient to achieve the goal within a timeframe. For example, if the goal is to educate the patient about insulin...
Planning Nursing Care I01:21

Planning Nursing Care I

The planning phase of the nursing process helps nurses set priorities, outline patient-centered goals and expected outcomes, and tailor nursing interventions to align with the aligned care plan. Through the planning phase, the nurse applies critical thinking skills to align and develop interventions according to the patient's needs. It provides continuity of care allowing patients to receive the maximum benefit from treatment. It serves as a pilot plan for allocating individual staff to a...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...